论文部分内容阅读
目的 :进一步探讨不同的治疗方法对乙型病毒性肝炎 (简称乙肝 )的治疗效果。方法 :设置治疗组和对照组 ,治疗组又分为抗病毒治疗 (干扰素 +胸腺肽 )和改善微循环等综合治疗为治疗一组 ;治疗二组为用干扰素和改善微循环的方法 ;治疗三组为胸腺肽和改善微循环的方法 ;对照组为单用改善微循环的方法 ;疗程为 3— 6个月。结果 :治疗各组乙肝标志物转阴率均高于对照组 ,e抗原受体治疗各组转阴率均 >5 3 % ,而对照组为 2 5 % ,二者具有显著差异。治疗各组的临床治愈好转率 >74% ,治疗组为 44 % ,二者具有高度显著差异。结论 :乙肝应在直接和(或 )间接抗病毒治疗的基础上 ,改善微循环 ,提高乙肝的临床治愈好转率。
Objective: To further explore the different treatment of hepatitis B (referred to as hepatitis B) treatment. Methods: The treatment group and the control group were set up. The treatment group was divided into antiviral therapy (interferon + thymosin) and microcirculation and other comprehensive treatment for the treatment of a group; treatment two groups with interferon and microcirculation method; treatment Three groups of thymosin and improve microcirculation method; control group is to improve microcirculation alone; course of treatment is 3-6 months. Results: The negative rate of Hepatitis B markers in each group was higher than that in control group. The negative rate of e antigen receptor in each group was> 53%, while that in control group was 25%. There was a significant difference between the two groups. The improvement rate of clinical cure in each group was> 74%, and that of the treatment group was 44%. There was a highly significant difference between the two groups. Conclusion: Hepatitis B should improve microcirculation on the basis of direct and / or indirect antiviral therapy and improve the cure rate of hepatitis B.